←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Trials, Dose Escalation Design
Mark J. Ratain
MD
🏢University of Chicago🌐USA
Leon O. Jacobson Professor of Medicine
90
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mark Ratain is a leading voice in cancer drug dose optimization and pharmacology-guided development. He has advocated for rational dose selection and post-marketing dose reevaluation of many approved oncology agents. His work directly informed the FDA Project Optimus initiative.
Share:
🧪Research Fields 研究领域
pharmacology
dose optimization
clinical pharmacogenomics
interventional oncology
drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mark J. Ratain 的研究动态
Follow Mark J. Ratain's research updates
留下邮箱，当我们发布与 Mark J. Ratain（University of Chicago）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment